Annual Retained Earnings
-$117.68 M
-$7.44 M-6.75%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings annual retained earnings is currently -$117.68 million, with the most recent change of -$7.44 million (-6.75%) on 30 September 2024. During the last 3 years, it has fallen by -$55.99 million (-90.76%). SONN annual retained earnings is now -845.98% below its all-time high of -$12.44 million, reached on 30 September 2019.SONN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$117.68 M
-$3.13 M-2.73%
30 September 2024
Summary:
Sonnet BioTherapeutics Holdings quarterly retained earnings is currently -$117.68 million, with the most recent change of -$3.13 million (-2.73%) on 30 September 2024. Over the past year, it has dropped by -$6.27 million (-5.63%). SONN quarterly retained earnings is now -303.22% below its all-time high of -$29.18 million, reached on 30 June 2020.SONN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SONN Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -6.8% | -5.6% |
| 3 y3 years | -90.8% | -73.3% |
| 5 y5 years | -846.0% | - |
SONN Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -90.8% | at low | -73.3% | at low |
| 5 y | 5 years | -846.0% | at low | -303.2% | at low |
| alltime | all time | -846.0% | at low | -303.2% | at low |
Sonnet BioTherapeutics Holdings Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | -$117.68 M(+6.7%) | -$117.68 M(+2.7%) |
| June 2024 | - | -$114.55 M(+3.2%) |
| Mar 2024 | - | -$111.05 M(-0.3%) |
| Dec 2023 | - | -$111.41 M(+1.1%) |
| Sept 2023 | -$110.24 M(+20.6%) | -$110.24 M(+3.5%) |
| June 2023 | - | -$106.57 M(+3.8%) |
| Mar 2023 | - | -$102.62 M(+5.8%) |
| Dec 2022 | - | -$96.95 M(+6.1%) |
| Sept 2022 | -$91.41 M | -$91.41 M(+8.9%) |
| June 2022 | - | -$83.98 M(+10.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$76.10 M(+12.1%) |
| Dec 2021 | - | -$67.89 M(+10.1%) |
| Sept 2021 | -$61.69 M(+68.1%) | -$61.69 M(+12.7%) |
| June 2021 | - | -$54.74 M(+12.6%) |
| Mar 2021 | - | -$48.62 M(+14.2%) |
| Dec 2020 | - | -$42.58 M(+16.0%) |
| Sept 2020 | -$36.71 M(+195.1%) | -$36.71 M(+25.8%) |
| June 2020 | - | -$29.18 M(-62.3%) |
| Mar 2020 | - | -$77.34 M |
| Sept 2019 | -$12.44 M | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual retained earnings?
- What is the all time high annual retained earnings for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual retained earnings year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly retained earnings?
- What is the all time high quarterly retained earnings for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly retained earnings year-on-year change?
What is Sonnet BioTherapeutics Holdings annual retained earnings?
The current annual retained earnings of SONN is -$117.68 M
What is the all time high annual retained earnings for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual retained earnings is -$12.44 M
What is Sonnet BioTherapeutics Holdings annual retained earnings year-on-year change?
Over the past year, SONN annual retained earnings has changed by -$7.44 M (-6.75%)
What is Sonnet BioTherapeutics Holdings quarterly retained earnings?
The current quarterly retained earnings of SONN is -$117.68 M
What is the all time high quarterly retained earnings for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly retained earnings is -$29.18 M
What is Sonnet BioTherapeutics Holdings quarterly retained earnings year-on-year change?
Over the past year, SONN quarterly retained earnings has changed by -$6.27 M (-5.63%)